Abstract
The goal was to study the possibility that Acinetobacter baumannii serve as an epidemiologically significant source for transmission of the blaNDM gene to Enterobacteriaceae by horizontal gene transfer (HGT) in hospitalized patients. The study was done at the Tel-Aviv Sourasky Medical Center from December 2014 until August 2015. Clinical and surveillance rectal cultures were collected as per hospital policies and were analyzed for the presence of New Delhi metallo-beta-lactamase-producing Enterobacteriaceae (NDME) and A. baumannii (NDMAb). Isolates were typed by pulsed-field gel electrophoresis (PFGE). The location of the blaNDM gene within the Tn125 transposon was studied by sequencing. A transmission event (TE) was determined if patients shared the same PFGE type of either NDME or NDMAb and were simultaneous in the same ward. HGT-related TE was considered if the two isolates shared identical blaNDM gene allele and transposon. There were 16 NDMAb- (clinical, 10; surveillance, 4; both, 2) and 13 NDME- (clinical, 3; surveillance, 8; both, 2) infected/colonized patients. All NDMAb isolates except two harbored the blaNDM-1 allele that was located within a Tn125 transposon and was plasmid borne. The majority of patients (n = 10/16) were infected by one PFGE type of NDMAb, and five clonal TEs were identified. NDME were either Escherichia coli (n = 4) or Klebsiella pneumoniae (n = 9) of different PFGE types with only one NDME TE. The blaNDM gene was within a Tn125 in three K. pneumoniae isolates. Although one HGT-related TE between NDMAb and K. pneumoniae was epidemiologically suspected, the low similarity between the Tn125 transposons (75.7%) excluded that possibility. In conclusion, whereas NDMAb appears to disseminate by clonal spread, we did not find evidence for HGT-mediated transmission in NDME in hospitalized patients.
Introduction
S
The mechanisms of the emergence and spread of NDM-producing Enterobacteriaceae (NDME) in Israel have remained elusive. In Israel and in other parts of the industrialized world, the first cases of NDME infections were reported in patients returning from the Indian subcontinent. 4 However, as soon as 2010, NDME were detected in patients without any connection with India 5 and now appear in various hospitals in Israel, including the post-acute care system. 3
One possible explanation for the emergence and spread of NDME in Israel, despite stringent control measures, is that there has been repeated exchange of the blaNDM gene between Acinetobacter baumannii and Enterobacteriaceae as previously suggested. 6 NDM-producing A. baumannii (NDMAb) was discovered in Israel as early as 2009. 7 In both NDME and NDMAb, the blaNDM gene is located within various types of transposons, most commonly the Tn125, 4 and can be found on both the chromosome and on plasmids.8,9 Hence, both due to its plasmid location and from an evolutionary perspective, the almost simultaneous emergence of the blaNDM gene in two bacterial populations is most likely explained by horizontal gene transfer (HGT) between them. 6 However, such events have never been traced epidemiologically nor have they been reported in other antimicrobial resistance genes.
The primary goal of this study was to study the possibility that A. baumannii serve as a source for transmission of the blaNDM gene to Enterobacteriaceae by HGT that is epidemiologically traceable and significant. For that we performed a comparative survey of the blaNDM gene in these two bacterial families, A. baumannii and Enterobacteriaceae. The secondary goals were to study the prevalence and molecular mechanisms of clonal- and HGT-mediated transmission of the blaNDM gene within each bacterial family.
Materials and Methods
Study design
This was an observational molecular-microbiological study that was conducted as an infection-control quality improvement project. The study was conducted at the Tel-Aviv Sourasky Medical Center (TASMC), a 1,400-bed hospital in Tel-Aviv, from December 2014 until August 2015. All NDME and carbapenem-resistant A. baumannii (CRAB) colonized/infected patients were prospectively identified based on routine laboratory testing (see below). Clinical and rectal surveillance cultures were collected according to the routine infection control and clinical practices. The standard control measures that were implemented were contact precaution and cohorting for NDME colonized/infected patients and contact precaution only for CRAB-infected patients.
Detection and identification of NDME and CRAB
Rectal surveillance cultures for CRAB and NDME were done using MacConkey with imipenem 1 μg/ml agar plates (HyLabs, Rehovot, Israel) as previously described. 10 Bacterial identification was done using VITEK®MS, and antimicrobial susceptibility testing was done by the VITEK®2 system (both by BioMerieux) and interpreted according to Clinical & Laboratory Standards Institute criteria. 11
Molecular typing and determination of resistance mechanisms
Isolates were tested by PCR for the blaNDM gene as previously described. 3 All NDME and NDMAb isolates were tested for the presence of the ISAba125 upstream to the blaNDM gene by PCR, using primers TRANSIS_F (5′-CGAGCATTACCAAAGGGTGA-3′) 12 and NDM1RG (5′-TAGTGCTCAGTGTCGGCATC-3′), generating a 1,300 bp fragment. Molecular typing was done by pulse-field gel electrophoresis in NDMAb 13 and NDME 14 isolates and also by blaOXA-51 sequencing 15 in NDMAb isolates.
Analysis of blaNDM-harboring transposons and plasmids
The plasmid location of the blaNDM gene was studied in isolates of all PFGE types. The location was determined by the ability to identify the blaNDM gene by PCR or by next-generation sequencing (NGS) on transferable plasmids as presented below. Plasmid DNA was purified from all isolates and transformed into E. coli DH10B. Transformants were selected on LB agar supplemented with ampicillin (100 mg/L) and confirmed by blaNDM-PCR. DNA of the blaNDM-harboring plasmids was then extracted from the transformants. 16 Sequence data were generated for the blaNDM-harboring plasmids 375 and 813 by NGS. Library preparation and sequencing were performed at Hy Laboratories Ltd. (Israel). Libraries were prepared using the NEBNext® Ultra™ DNA Library Prep Kit for Illumina (New England Biolabs). Libraries were checked for size distribution using a TapeStation 2200 (Agilent) and were sequenced on an Illumina MiSeq using the MiSeq V2 Reagent Kit (500 cycles). De novo assembly was carried out using SPAdes software with default parameters. The blaNDM-harboring plasmid analyses included determination of the genetic environment surrounding the blaNDM gene 12 and the plasmid's Inc. types.17,18
Data analysis of transmission events
Transmission events (TEs) of NDME and/or NDMAb were defined according to combined epidemiological and molecular criteria: (1) epidemiological: (a) the recipient case of NDME/NDMAb was defined as hospital-acquired if NDME/NDMAb were detected after more than 48 hours of admission and (b) the donor case was hospitalized in the same ward, at least 1 week before the first isolation of NDME/NDMAb in the recipient; (2) molecular: (a) clonal TEs—same bacterial species and PFGE type or (b) HGT-mediated TEs (only if clonal TEs excluded)—same blaNDM gene allele and transposon. 16
Results
During the 9 months studied, 13 patients carrying NDMEs were hospitalized. During this period, 313 patients had CRAB, of which 16 cases (5.1%) were NDMAb. Co-carriage of NDME and NDMAb was not found. The microbiological and molecular features of the NDME and NDMAb isolates are presented in Table 1. Most NDMAb (12/16) were isolated from clinical sites, including sputum (n = 5), blood (n = 4), urine (n = 3), peritoneal fluid (n = 1), and wound (n = 1), exclusively or combined with rectal surveillance culture. In contrast, only 5/13 of NDME were isolated from clinical sites, including wound (n = 3), sputum, and urine (n = 1 for each).
CPE, carbapenemase-producing Enterobacteriaceae; CRAB, carbapenem-resistant A. baumannii; NDMAb, New Delhi metallo-beta-lactamase-producing A. baumannii; NDME, NDM-producing Enterobacteriaceae; PFGE, pulsed-field gel electrophoresis.
The majority of NDMAb isolates (10/16) belonged to a single PFGE type that was responsible for five clonal TEs. In all PFGE types except one the blaNDM gene was plasmid borne and was typed as blaOXA-66. The latter PFGE type (two isolates) was typed as blaOXA-70 and also carried the blaNDM-2 allele; it is likely that in these isolates the blaNDM gene was located on the chromosome. Both E. coli and K. pneumoniae NDME belonged to diverse clonal structure. Although 9/13 cases were hospital acquired, only one clonal TE of K. pneumoniae NDME was identified. Hence, the source for most NDME cases (8/13) remained undetermined.
Despite the plasmid location of the blaNDM gene in all NDME and 4/5 of NDMAb PFGE types, the other molecular features excluded the possibility of HGT-mediated transmission between NDME and from NDMAb in most of the cases: (1) the blaNDM gene allele differs in E. coli (blaNDM-5) versus K. pneumoniae NDME and NDMAb (blaNDM-1); (2) the Tn125 was present in all NDMAb but in only 3/9 of K. pneumoniae NDME.
Epidemiologically, only one of the three Tn125-positive K. pneumoniae NDME was hospital acquired (case 375) and was also related to one potential HGT-mediated TEs from NDMAb (case 813). However, although the blaNDM gene was located inside a Tn125 in both isolates, the extent of the similarity (75.7%) between the two transposons (Supplementary Fig. S1; Supplementary Data are available online at www.liebertpub.com/mdr) excluded the possibility of TEs. In accordance with this finding, the plasmid Inc types were also different: 375-IncFII, A4; 813-GR3.
Discussion
In Israel and in our institution, CRAB has emerged at the beginning of the millennium as an important nosocomial pathogen and a major cause of bacteremia. 19 Our study provides several novel findings regarding the epidemiology of NDMAb. First, the rate of NDMAb among CRAB was found to be relatively low (5.1%), despite the evidence for clonal spread. Epidemiological data are lacking in studies from European countries, 20 but this rate (5.1%) is higher than the rates reported from Turkey (2/68, 2.9%), 21 the United Arab Emirates (2/155, 1.2%), 22 and China (4/2,109, 0.2%). 23 This emphasizes the relative importance of NDMAb in Israel compared with other countries. Second, we observed an inverse proportion of clinical versus rectal surveillance culture isolates of NDMAb versus NDME. This was caused most likely by the fact that CRAB may colonize other anatomic sites that were not sampled. 13 Hence, the actual number of colonized patients is likely to be higher. Third, in all NDMAb isolates the blaNDM gene was located inside a Tn125 transposon, but unlike the previous report from Israel, 7 the allele was blaNDM-1 (and not blaNDM-2), and the gene was harbored by plasmids. Together, these molecular and epidemiological features suggest that although NDMAb by itself does not constitute a major problem within the CRAB epidemic, its prevalence is similar to NDME and it possesses the potential to serve as reservoir for HGT-mediated spread of the blaNDM gene. 6
From epidemiological and infection control perspectives, the lack of HGT-mediated TEs of the blaNDM gene between bacterial families in our study is important. Although our study is too small to exclude that possibility from a broad evolutionary perspective, it points that unlike interspecies intrafamily transmission,24,25 such events are probably too rare to be accounted as a possible source for transmission in the course of an outbreak. Therefore, identification of the blaNDM gene should not be actively sought in CRAB-infected/colonized patients in the context of NDME outbreak.
NDM and other antimicrobial resistance genes can disseminate in the healthcare system by two molecular mechanisms. Although clonal spread is more easily noticeable, HGT of carbapenemase genes is of no lesser importance and has been responsible for the spread of these genes across states and even continents. 26 Epidemiologically, HGT-mediated TEs can be traced when different CPE species harboring the same carbapenemase gene are isolated in the same patient 16 or their isolation in several patients in the context of a local outbreak. In this study we have setup a novel approach to trace HGT-mediated transmission of the blaNDM gene between bacteria of different families. Although we have failed to identify such TEs, we believe that from an evolutionary perspective, it is very likely that such events have occurred and their study is of crucial importance for the understanding of the evolution of antimicrobial resistance. Therefore, we think that a study of such events should be sought in a multicenter study of longer duration.
Footnotes
Acknowledgments
The authors thank Dr. Chaim Wachtel from the Hylabs Company, for his assistance in the preparation of this article. The work done by author R.G. was performed in partial fulfillment of the requirements for a PhD degree in the Faculty of Medicine, Tel-Aviv University.
Disclosure Statement
No competing financial interests exist.
References
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
